HOME >> BIOLOGY >> NEWS
454 sequencing identifies HIV drug resistance at early stage

BRANFORD, Conn., June 15, 2007 454 Life Sciences, a member of the Roche group, and a Yale School of Medicine researcher today announced that they have used the companys Genome Sequencer system to identify previously undetectable rare drug resistant HIV variants in samples from an earlier performed clinical trial. The work, presented today by Michael Kozal, M.D. of the Yale University School of Medicine and the VA CT Health Care System, was a blinded-retrospective analysis of 258 blood samples taken before drug treatment from HIV infected individuals. The results were presented today at the XVI International HIV Drug Resistance Workshop in Barbados and showed that the fraction of patients that harbored resistance mutations is at least twice as high as previously thought. Most low level mutations are undetectable by current resistance testing methods that are used in the clinic. The additional low abundant resistant variants detected by Ultra Deep sequencing were found to be extremely important as it enabled the prediction of early antiretroviral treatment failure with strong statistical significance.

Current genotypic resistance technology available to clinicians is limited to detecting resistance mutations that are present at levels of approximately 20% or greater in the circulating viral population in a patient. Thus, the current technology used in the clinic may miss many low-level resistant HIV strains which can grow rapidly under drug selection pressure and lead to therapy failure. This retrospective study clearly shows that even resistance mutations present at the 1% level lead to premature failure of therapy explained Michael Kozal, M.D. the senior author on the study. In the future, hopefully clinicians can use this knowledge to choose better antiretroviral drug combinations that have the ability to suppress these resistant HIV strains which will lead to better clinical responses in patients.

While treatment of HIV has been largely s
'"/>

Contact: Tony Russo
tony.russo@russopartnersllc.com
212-845-4251
Russo Partners, LLC
15-Jun-2007


Page: 1 2

Related biology news :

1. New grants bolster efforts to generate faster and cheaper tools for DNA sequencing
2. Back to the future: Mastodon extends the time limit on DNA sequencing
3. Liverpool amongst first in UK to install unique DNA sequencing technology
4. Discovery could help bring down price of DNA sequencing
5. Ultra deep sequencing identifies HIV drug resistance at early stage
6. 454 Life Sciences and Baylor College of Medicine complete sequencing of DNA pioneer
7. LSU professor involved in genome sequencing of the first marsupial
8. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
9. Gene sequencing advance will aid in biomass-to-biofuels conversion
10. Genome sequencing reveals key to viable ethanol production
11. Faster, low cost sequencing technologies needed to drive era of personalized medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... January 09, 2020 , ... Cutting Edge Spine, a ... 510(K) clearance and commercial launch of the latest addition to its bioactive portfolio ... EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced material supplied by Invibio Biomaterial Solutions. ...
(Date:1/7/2020)... ... January 07, 2020 , ... Lifecycle Biotechnologies ... part numbers like what can be found in most catalogs, but rather, insightful ... is all linked to the impact it has on the global life science ...
(Date:1/2/2020)... FORT WORTH, Texas (PRWEB) , ... January 02, ... ... to provide custom and semi-custom aqueous reagents, chemicals, and medias, as well as ... cellular agriculture, and cell- and tissue-based product manufacturers. , “We are excited ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... , ... January 24, 2020 , ... The plastic and ... Surgery Center in New Jersey epitomize the notion that plastic surgery is much more ... characterized in popular media. , Over the last 20 years NJ Top Docs, Dr. ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal ... cosmetic surgery industry at two recent North American investor forums specializing in medical ... Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 in New York ...
(Date:1/22/2020)... DIEGO (PRWEB) , ... January 21, 2020 , ... ... to challenges with the precision of Genome editing. The partners have agreed to ... control (QC) of CRISPR research, agricultural, and pre-clinical programs. Over the longer-term, the ...
(Date:1/10/2020)... ... January 09, 2020 , ... Phlexglobal, the ... the acquisition of Cunesoft, a move that expands the company’s portfolio of best-of-breed ... sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent software and expert ...
Breaking Biology Technology:
Cached News: